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Immunohistochemical study of vl-5 chains of type IV collagen in
hereditary nephritis. The distribution of al-5 chains of type IV collagen
[al-5(IV)] in the glomerular basement membrane (GBM) and epidermal
basement membrane (EBM) of 23 families with hereditary nephritis was
examined by indirect immunofluorescence. These families were divided
into three clinicopathological groups. Group I (10 families) patients
showed a widespread "basket weave" pattern of the GBM and a family
history of nephritis was present. Group II (6 families) patients showed a
widespread "basket weave" change without a family history of nephritis.
Group III (7 families) patients showed a widespread attenuation of the
GBM but no "basket weave" change, and had a family history of nephritis
and chronic renal failure. al(IV) and a2(IV) were present in all affected
and unaffected family members and controls. All normal family members
and controls expressed a3(IV), a4(IV) and a5(IV) in the GBM and
a5(IV) in the EBM in a diffuse pattern. All group I families and three of
the group II families exhibited complete loss of the a5(IV) antigen from
the GBM and EBM in male patients, and segmental loss of the a5(IV)
antigen in female patients. In these families the a3(IV) and a4(IV)
antigens were completely lost from the GBM in male patients with severe
nephritis, whereas a3(IV) and a4(IV) were present but diminished in
male patients with mild nephritis. Three group II and all group III families
expressed the a3-5(IV) antigens in an identical manner to that of normal
controls. These findings indicate that the heterogeneity of hereditary
nephritis reflects a variety of aberrant expression patterns of a3-5(IV) and
that immunohistochemical examination of a5(IV) in the EBM is a useful
method for the diagnosis of X-linked Alport syndrome.
Hereditary nephritis is a familial disorder which generally has a
progressive course. It is usually present with hematuria in child-
hood, and when associated with neurosensory deafness it is known
as Alport syndrome [1]. Characteristic alterations of the glomer-
ular basement membrane (GBM) are observed on electron mi-
croscopy [2—4]. There is irregular thickening of the GBM with
replication of the lamina densa, forming a "basket weave" pat-
tern, and enclosing electron-lucent lacunae which frequently
contain small dense particles. When diffuse, these changes are
diagnostic of Alport syndrome [5]. A widespread basket weave
pattern of the GBM has also been reported in patients with
hematuria but no family history of nephritis, and it has been
suggested that such GBM changes in patients with nonfamilial
hematuria may represent new mutations of Alport syndrome
[6—8]. However, a widespread basket weave GBM pattern is not
present in all patients with hereditary nephritis; some patients
show a widespread attenuation of the GBM instead [9].
Alport syndrome is a genetically heterogeneous renal disease.
X-linked dominant, autosomal dominant and autosomal recessive
modes of inheritance have been reported [10—12]. However, the
majority of Alport pedigrees published show X-linked dominant
inheritance [11].
The characteristic GBM alterations in patients with Alport
syndrome suggest that the defect is expressed in one of the
structural components of the GBM. Abnormalities in the type IV
collagen of the GBM have been heavily implicated in the patho-
genesis of Alport syndrome. The type IV collagen molecule has a
triple-helical structure composed of 3 a chains [13]. There are five
isoforms of these chains in the GBM: al(IV), a2(IV), a3(IV),
a4(IV) and a5(IV). Recently the gene for a sixth chain, a6(IV),
has been identified [14]. These triple-helical type IV collagen
molecules comprise the GBM network [15]. Alterations of the
Goodpasture antigen and the Alport antigen in the GBM have
been reported in Alport patients [10, 16—21], as have alterations
of the Alport antigen in the epidermal basement membrane
(EBM) [22, 23]. Goodpasture antigen is localized to the NC1
domain of a3(IV) [24, 25], while the Alport antigen and the NC1
domain of a5(IV) may be the same or homologous molecules [26].
The a3(IV) gene maps to chromosome 2 [27] and the aS(IV) gene
maps to the long arm of the X chromosome [28]. Mutations in the
a5(IV) gene have been reported in X-linked Alport syndrome [29,
30], and recently mutations in the a3(IV) and a4(IV) genes have
been identified in autosomal recessive Alport syndrome [31].
Since very little data about the proteins are available for a
chains of type IV collagen in hereditary nephritis, in the present
study we examined the distribution of al(IV), a2(IV), a3(IV),
a4(IV) and a5(IV) in the GBM and EBM of patients with
hereditary nephritis using indirect immunofluorescence, and here
we discuss the relationship of the distribution of these chains to
the clinical and pathological features.
Methods
Families
Forty-four members from 23 families with familial nephritis
were examined after obtaining their informed consent. These
families were divided into three clinicopathological groups.
1413
Received for publication February 18, 1994
and in revised form May 27, 1994
Accepted for publication June 1, 1994
© 1994 by the International Society of Nephrology
1414 Nakanishi et a!: Type IV collagen in hereditaiy nephritis
Group I (families 0K OG, KA, IN, TO, HO, KO, YA, SA, and
MA). Patients showed a widespread "basket weave" pattern of the
GBM, and a family history of nephritis was present.
Group II (families SI, OA, YO, SM, TE and SB). Patients showed
a widespread "basket weave" pattern of the GBM, but a family
history of nephritis was absent.
Group IH (families UM, NI, MR, YG, NO, MK and 00).
Patients showed a widespread attenuation of the GBM but no
"basket weave" pattern. Attenuation of the GBM was defined as
a thickness of less than 250 nm [32]. A family history of nephritis
and chronic renal failure was present.
The clinical and electron microscopic features are summarized
in Table 1.
In group I, each family exhibited an inheritance pattern com-
patible with X-linked transmission; there was mother-to-son or
mother-to-daughter transmission, absence of father-to-son trans-
mission, and nephritis was more severe in male patients than in
females. However, it was often difficult to exclude the possibility
of an autosomal inheritance mode from the family history as the
families were small. In four families, neurosensory deafness was
present in male patients with nephritis. Cataract was found in
male patients in two families, but no other ocular anomalies were
found in group I patients with nephritis. In six families, progres-
sion to renal failure was observed in male patients and a male
patient in family OG received a kidney transplant from his father.
He has not developed post-transplant anti-GBM nephritis. The
age at onset of end-stage renal disease (ESRD) was less than 20
years in five families, but more than 30 years in one family. In
families KA, TO and YA there was only one male patient in each
family and nephritis appeared severe in these male patients. In
families SA and MA nephritis appeared milder in male patients.
First renal biopsy of a male patient in family MA at the age of
seven years showed widespread attenuation of the GBM without
a basket weave change, but his second biopsy at the age of 15 years
showed a widespread "basket weave" pattern.
In group II only a single subject was affected in each family. No
family exhibited consanguinity. There were two male and four
female patients with nephritis. Four patients showed neurosen-
sory deafness. One male patient from family SI had a cataract, but
no other ocular anomalies were found in group II patients. Two
patients developed ESRD before the age of 20 years and received
kidney transplants from their parents. They have not developed
post-transplant anti-GBM nephritis.
In group III, neurosensory deafness was present in three
families. No ocular anomalies were found in group III patients
with nephritis. The age at onset of ESRD was more than 30 years
in all families. Figure 1 shows pedigrees of group III families.
Tissue
Kidney tissues were obtained by percutaneous renal biopsy,
using a Tru-Cut needle under X-ray control or ultrasonic guide,
from 25 patients belonging to 22 families. Renal tissues from
normal subjects in families OG, SI and SM were obtained from
transplanted kidneys at the time of renal transplantation. Five
other normal renal biopsy specimens obtained at the time of renal
transplantation were used as normal controls.
Skin specimens (4 mm in diameter) were obtained by punch
biopsy from the volar aspect of the forearm from 37 members of
18 families. Skin biopsy specimens obtained from one healthy
volunteer and two patients with other renal diseases, and histo-
logically normal specimens of skin obtained from four individuals
were used as normal controls. Both kidney and skin were studied
in 17 families, kidney alone in five, and skin alone in one.
Antibodies
Polyclonal antibodies anti-al(IV), anti-a2(IV), and anti-
a3(IV), and mouse monoclonal antibody to anti-a3(IV) NC1
(MAb17) [33—35] were provided by Dr. J. Wieslander (Statens
Seruminstitut, Copenhagen, Denmark). The polyclonal antibodies
were obtained from rabbits immunized with bovine NC1 domain
[33, 36]. Monoclonal anti-c4(IV) NC1 antibody (MAb85) ob-
tained from mice was provided by Dr. R.J. Butkowski (University
of Minnesota, Minnesota, USA) [36]. Another monoclonal anti-
s4(IV) NC1 peptide antibody (MK4) was also used. This was
made by immunizing mice with a rat NC1 fraction [37] and
reacted with a derived non-consensus amino acid sequence (PAP-
DTLKESQ) [38]. Monoclonal anti-a5(IV) NC1 peptide antibody(H51) was also made by immunizing rats with a derived non-
consensus amino acid sequence (VDVSDMFSKPQSE) [39].
MAb85 was diluted to 1:20 with PBS for the use of immunohis-
tochemical study. The other antibodies were not diluted for the
use of immunohistochemical study.
Indirect immunofluorescence
Kidney and skin tissues were snap-frozen in a dry ice and
acetone bath. They were cut into 4 m sections, air dried, fixed in
95% ethanol at 4°C for five minutes, and rinsed three times with
PBS at room temperature. Kidney and skin tissue sections for
immunostaining with primary antibodies against a3(IV), c4(IV)
and a5(IV) were denatured in 6 M urea, 0.1 M glycine HC1 buffer,
pH 3.5, at 4°C for one hour [40], and then washed three times with
PBS prior to reacting with primary antibodies. The sections were
stained by an indirect method using the primary antibodies against
al(IV), s2(IV), cx3(IV), a4(IV) and a5(IV). After reaction for 45
minutes at room temperature, secondary antibodies, fluorescein
isothiocyanate (FITC)-conjugated goat [F(ab')2] anti-rat IgG,
FITC-conjugated goat [F(ab')2] anti-mouse IgG and FITC-con-
jugated goat [F(ab')2] anti-rabbit IgG (Organon Teknika-Cappel,
Durham, North Carolina, USA) were added. Secondary antibod-
ies were diluted to 1:60 with PBS before the use. The sections
were viewed with an Olympus BH2-RFCA reflecting microscope
(Olympus Optical Co., Tokyo, Japan).
To demonstrate the relationship between glomerular a3(IV) or
a4(IV) and a5(IV) distribution in a group I female patient, dual
fiuorochrome immunofluorescence was carried out. Renal tissue
was first stained with anti-a5(IV) antibody, which was detected
with FITC-conjugated goat [F(ab')2] anti-rat IgG, and then
stained with anti-a3(IV) or anti-a4(IV) antibody which was
detected with rhodamine-conjugated goat [F(ab')2] anti-rabbit
IgO or rhodamine-conjugated goat [F(ab')2] anti-mouse IgG,
respectively (Organon Teknika-Cappel).
Results
In glomeruli from normal control kidney tissues al(IV) and
a2(IV) were distributed in a diffuse pattern through the GBM and
mesangium, while cx3(IV), a4(IV) and c5(IV) were confined to
the GBM. In normal control skin tissues al(IV), a2(IV) and
a5(IV) were diffusely distributed in the EBM, but a3(IV) and
a4(IV) were absent in the EBM (Fig. 6).
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Table 1. Clinicopathological findings and distribution of a3, 4 and 5 chains of type IV collagen in the glomerular basement membrane and
epidermal basement membrane
Family End-stage
Affected males Affected females
Number of Number of
history of renal disease subjects subjects
Family nephritis Deafness Cataract (onset age) GBM changes examined a3 a4 aS examined a3 a4 aS
Group I
OK + ÷ + +
(<20 years)
basketweave 2 — — — GBM,EBM 1 +s EBM
OG + + + +
(<20 years)
basket weave 2 — — — GBM,EBM
KA + + basket weave 1 — — — GBM,EBM 1 +s EBM
IN + + +
(<20 years)
basket weave 2 +s +s +s GBM,EBM
TO + basket weave 1 — — — GBM
HO + +
(<20 years)
basket weave 3 +s +s +s GBM,EBM
KO + +
(<20 years)
basket weave 3 +s EBM
YA + basket weave 1 — — — GBM,EBM 1 +s EBM
SA + basket weave 1 — GBM,EBM 1 +s EBM
MA + +
(>30years)
basket weave 1 — GBM,EBM 1 +s EBM
Group II
SI + + +
(<20years)
basket weave 1 — — — GBM,EBM
OA + basket weave 1 — — — GBM,EBM
YO basket weave 1 +s +s +s GBM,EBM
SM + +
(<20years)
basket weave 1 +d EBM
it + basket weave 1 +d +d +d GBM,EBM
SB basket weave 1 +d +d +d GBM
Group III
UM + + +
(>30 years)
attenuation 1 +d +d +d GBM 1 +d +d +d GBM
NI + + +
(>30 years)
attenuation 1 +d +d +d GBM





attenuation 1 +d +d +d GBM,EBM 1 +d EBM
NO + +
(>30 years)
attenuation 1 +d +d +d GBM,EBM
MK + +
(>30 years)
attenuation 1 +d +d +d GBM
00 + +
(>30 years)
attenuation 1 +d +d +d GBM
Normal males Normal females
Number of Number of
subjects subjects
Family examined a3 a4 aS examined a3 a4 aS
Group I
OK










SI 1 +d +d +d GBM 1 +d EBM
OA 1 +d EBM
YO 1 +d EBM
SM 1 +d +d +d GBM,EBM
TE
SB
Abbreviations are: +, strongly positive staining; slightly positive staining; —, negative staining; d, diffuse distribution; s, segmental distribution;
GBM, glomerular basement membrane; EBM, epidermal basement membrane.
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Family UM Family MR Family NI Family YG
oT
a a e iGS a
Fig. 1. Pedigrees in group III families. Squares (U) and circles (0) denote males and females, respectively. Solid symbols (S •) denote individuals with
end-stage renal disease and white cross-hatched symbols (rA ?A) indicate individuals with hematuria. G indicates subjects who had renal biopsy and E
indicates subjects who had skin biopsy. D indicates subject with deafness.
Fig. 2. Normal glomeruli stained with anti-cs3(IV) (A), anti-a4(IV) (B) and anti.a5(IV) (C) antibodies. There is diffuse linear binding of anti-a3(IV),
anti-a4(IV) and anti-a5(IV) antibodies to the OBM (X270).
al(IV) and a2(IV) were clearly detected along the GBM and
EBM in all family members examined.
The results of the indirect immunofluorescence studies of
a3(IV), a4(IV) and a5(IV) in the GBM and EBM are presented
in Table 1. A diffuse pattern of a3(IV), cs4(IV) and aS(IV) was
observed in the OBM of all normal family members examined
(Fig. 2), and diffusely distributed a5(IV) was also present in the
EBM of all normal family members examined (Fig. 6C).
In group I all male patients showed complete absence of the
a5(IV) antigen from the GBM (Figs. 3C and 4C) and EBM (Fig.
7A). A segmental distribution of the a5(IV) antigen was observed
in the GBM (Fig. 5C) and EBM (Fig. 7B) of all female patients.
The male patients from families OK, 00, KA, TO and YA
showed complete absence of the a3(IV) and a4(IV) antigens from
the OBM (Fig. 3A and B), whereas diminished but diffuse staining
of the GBM with anti-a3(IV) and cx4(IV) antibodies was demon-
strated in male patients from families SA and MA, in which
nephritis appeared milder (Fig. 4A and B). Female patients from
families IN and HO exhibited a segmental distribution of a3(IV)
and a4(IV) in the GBM (Fig. 5A and B). Dual label immunoflu-
orescence in a female patient from family HO demonstrated that
a3(IV) and a5(IV) were similarly distributed in her GBM, as
were is4(IV) and a5(IV) (Fig. 8). Thus, a5(IV) was codistributed
with a3(IV) and a4(IV) in this patient's GBM.
In group II, cs5(IV) expression in both the GBM and EBM was
completely absent in male patients from families SI and OA, and
a segmental a5(IV) distribution was observed in the OBM and
EBM of the female patient from family YO. The male patients
from families SI and OA also showed a complete absence of the
a3(IV) and a4(IV) antigens from the GBM, while the female
patient from family Y0 showed a segmental distribution of
a3(IV) and a4(IV). The expression pattern of the a3(IV), a4(IV)
op.
Family NO Family MK Family 00
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Fig. 3. Glomeruli of a group I male patient with severe nephritis (family OK) stained with anti-a3(IJ/) (A), anti-a4(IV) (B) and anti-cs5(IV) (C) antibodies.
No binding of anti-a3(IV), anti-a4(IV) or anti-a5(IV) antibodies to the GBM was observed (X270).
Fig. 4. Glomen4i of a group I male patient with mild nephritis (family SA) stained with anti-a3(IV) (A), anti-a4(IV) (B) and anti-aS (I V) (C) antibodies.
There was diminished binding of anti-a3(IV) and anti-a4(IV) to the GBM, but no binding of anti-a5(IV) antibody (X270).
Fig. 5. Glomeruli of a group I female patient (family HO) stained with anti-a3(IV) (A), anti-a4(IV) (B) and anti-a5(IV) (C) antibodies. There was
segmental linear binding of anti-a3(IV), anti-a4(IV) and anti-a5(IV) antibodies to the GBM (X270).
and a5(IV) antigens in these three patients from group II was
therefore identical to that in the group I patients. The mothers of
the three group II patients with abnormal a5(IV) expression
showed normal expression of aS(IV) in the EBM. The female
patients from the other three families in group II demonstrated
normal a5(IV) expression in both the GBM and EBM. These
female patients also showed normal expression of a3(IV) and
a4(IV) as well as a5(IV) in the GBM.
Families in group III expressed a5(IV) in the GBM and EBM,
and a3(IV) and a4(IV) in the GBM, in an identical pattern to that
of normal controls.
al(IV) and a2(IV) were also localized in Bowman's capsule,
the tubular basement membrane and the vascular basement
membrane of kidney tissues from normal controls and all affected
and unaffected individuals examined. a3(IV) and r4(IV) were
also distributed occasionally in the tubular basement membrane
and segments of Bowman's capsule of normal control kidney
tissues. a5(IV) was also detected in Bowman's capsule and the
basement membranes of some tubules of normal control kidney
tissues. The expression patterns of a3(IV), a4(IV) and a5(IV) in
Bowman's capsule and the tubular basement membrane, and the
GBM were always identical in affected and unaffected individuals
examined.
Skin tissues of four male and two female patients from families
OK, OG, IN, HO, MA and SI, and two normal controls were
examined by electron microscopy. These six patients showed
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Fig. 6. Normal skin biopsy specimens stained with anti-cv3(IV) (A), anti-a4(JV) (B) and anti-a5(IV) (C) antibodies. There is diffuse linear binding of
anti-a5(IV) antibody to the epidermal basement membrane (EBM) (black arrow), but no binding of anti-s3(W) and anti-a4(IV) antibodies to the EBM
is observed (white arrow) (X410).
Fig. 7. Skin biopsy specimens from a group I
male patient (family OK) (A) and a group I
female patient (family OK) (B) stained with anti-
a5(IV antibody. No binding of anti-a5(IV)
antibody to the EBM (white arrow) was
observed in the male patient's skin (A) (X410).
There was segmental binding of anti-a5(IV)
antibody to the EBM in the female patient's
skin (B) (X410). Note normal binding areas
(black arrow) and no binding areas (white
arrow) of the EBM.
abnormal expression of a5(IV) in the GBM and EBM and a
widespread "basket weave" pattern of the GBM. The EBM was
not different among these specimens (Fig. 9). The "basket weave"
changes in the EBM were not observed.
Discussion
Alterations in antigenicity of the GBM have been previously
reported in Alport syndrome [10, 16—23, 39, 41, 42]. After renal
transplantation, some patients with Alport syndrome have devel-
oped anti-GBM nephritis in their renal allografts [17, 19, 21]. The
patients' anti-GBM sera reacted with control kidneys, but not with
the native kidney or the kidneys of other patients with Alport
syndrome [17]. IgG in sera from patients with Goodpasture
syndrome binds to normal GBM, but not to the GBM of some
patients with Alport syndrome [16—18, 201. These findings suggest
the absence of GBM antigens, Alport and Goodpasture antigens
in some patients with Alport syndrome. The Goodpasture antigen
is located in the NC1 domain of 3(IV) [24, 25], while the Alport
antigen and the NC1 domain of a5(IV) are possibly the same or
homologous molecules [26].
Iamilies in group I are typical examples of Alport syndrome
since a widespread basket weave pattern is present in the GBM of
the patients, and nephritis is present in at least two members of
each family. Four families (families OK, OG, KA and IN), in
which neurosensory deafness is also present, are classical exam-
ples of Alport syndrome. All group I families showed an abnormal
expression of a5(IV). Unaffected family members showed diffuse
linear expression of a5(IV) in the GBM and EBM, however, male
patients showed no reactivity of the GBM and EBM with anti-
a5(IV) antibody and female patients exhibited segmental reactiv-
ity. The distribution of this a5(IV) defect is consistent with
X-linked dominant transmission of an abnormal gene, and the
V"Y;:-
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Fig. 8. Dual label immunofluorescence in a
group I female patient (family HO) stained with
anti-cd(IV) (A) and anti-a5(IV) (B) antibodies,
and anti-a4(IV) (C) and anti-a5(IV) (D)
antibodies. a3(IV) and a5(IV) were similarly
distributed in the GBM, as were a4(IV) and
a5(IV) (X270).
Fig. 9. Electron micrographs of normal skin (A) and skin of a group I male patients (family OK) (B). The "basket weave" changes were not observed in
the epidermal basement membrane (EBM) (black arrows). There was no apparent abnormalities of the EBM (x 16,000).
a5(IV) gene is known to be located on the X-chromosome. Male
patients, who only possess the abnormal a5(IV) gene, produce
only abnormal a5(IV) which is not detected by anti-a5(IV)
monoclonal antibody. The a5(IV)-producing cell in female pa-
tients may have either an active normal a5(IV) gene or an active
abnormal gene, depending on which X chromosome is randomly
inactivated [22]. As a result, female patients have a mixture of
normal and abnormal a5(IV). Furthermore, a number of muta-
tions have been found in the cs5(IV) gene in families with Alport
syndrome [29, 30}. Therefore all the families in group I were
considered to have an X-linked type inheritance mode. Autoso-
mal dominant and autosomal recessive modes of inheritance have
been reported [10—12], and recently mutations in the a3(IV) and
a4(IV) genes have been identified in autosomal recessive Alport
syndrome [31]. However, the present findings indicate that a
majority of families with Alport syndrome show an abnormal
expression of a5(IV) and an X-linked type of inheritance mode.
Patients in group II did not appear to have hereditary nephritis,
because nephritis was lacking in their families. However, in our
previous study, children with a widespread basket weave pattern
of the GBM, with or without a family history of nephritis, showed
a tendency to show a progressive disease course, more frequent
occurrence of neurosensory deafness, and a more severe progno-
sis in boys [8]. We were not able to identify any other clinical or
pathological features that distinguish such nonfamilial patients
from Alport patients. Three patients in group II showed abnormal
expression of a5(IV) identical with the abnormal expression
observed in group I. Their mothers showed normal a5(IV)
I
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expression. We suspect that these three patients may represent
new mutations in X-linked Alport syndrome. Analysis of the
cs5(IV) gene revealed a mutation in a female patient from family
YO. This girl patient showed a segmental a5(IV) distribution in
the GBM and EBM.
In the present study, abnormal expression of the a5(IV) antigen
was always associated with abnormal expression of the a3(IV) and
a4(IV) antigens in the GBM. Male patients showed complete loss
of the a3(IV) and o4(IV) antigens in the families with severe
disease and diminished expression in the families with mild
disease. Female patients showed segmental expression of the
a3(IV) and a4(IV) antigens. Dual-label immunofluorescence
demonstrated that the cr3(IV), a4(IV) and a5(IV) antigens were
codistributed in the GBM. Abnormal expression of the a5(IV)
antigen in the skin, where a3(IV) and a4(IV) are normally absent,
and the presence of a3(IV) and cs4(IV) in the glomeruli of some
male patients without a5(IV) antigen suggest that a defect of
a5(IV) leads to defect of a3(IV) and a4(IV) in the GBM. The
mechanism of the abnormal a3(IV) and a4(IV) expression in
patients with abnormal a5(IV) has been discussed by Kashtan et
al [43} and Reeders [44], but remains to be established. Although
primary abnormalities may be present in the a5(IV) gene, the
severity of the disease is associated with the expression of a3(IV)
and a4(IV). Gubler, Antignac and Knebelmann [45] recently
reported that absence of a3(IV) antigen was a marker of severe
juvenile forms of Alport syndrome.
In contrast to group I patients, all patients in group III showed
normal expression of the a3(IV), a4(IV) and 5(IV) antigens.
Group III patients were characterized by a thin GBM. The
relationship between thin GBM disease and Alport syndrome is
unknown. Progression may be evident from thinning of the GBM
to basket weave changes in the GBM in some patients, as in our
male patient of family MA in group I. His first biopsy at the age
of seven years showed widespread attenuation of the GBM
without a basket weave change, but his second biopsy at the age of
15 years showed a widespread basket weave change. Therefore, it
is possible that thin GBM disease and Alport syndrome may be
variants of the same disease [44]. However, the present study
showed that thin GBM disease and Alport syndrome are different
diseases in the majority of patients.
The expression patterns of a5(IV) in the GBM and EBM were
always identical. Therefore immunohistochemical examination of
skin biopsy specimens could be of diagnostic value. A diagnosis of
X-linked Alport syndrome can be made by means of skin biopsy
using anti-cs5(IV) antibody in male patients. However, the use of
skin biopsy for X-linked Alport syndrome should be cautious in
female patients with hematuria. Because of mosaicism a normal
result does not unequivocally exclude heterozygosity. The basket
weave changes in the EBM were not observed in patients with a
widespread basket weave pattern of the GBM. Our observations
agree with the observations of Kashtan et al [46], who also found
no apparent abnormalities in the EBM of Alport patients.
In conclusion, the heterogeneity of hereditary nephritis reflects
the variety of aberrant expression of a3(IV), a4(IV) and a5(IV),
and immunohistochemical examination of cx5(IV) in the EBM is
useful for diagnosis of X-linked Alport syndrome.
Acknowledgments
The authors are grateful to Dr. J. Wieslander (Statens Seruminstitut,
Copenhagen, Denmark) for kindly providing anti-csl(IV), anti-c2(IV),
anti-a3(IV) and MAb17 antibodies, and Dr. R.J. Butkowski (University of
Minnesota, Minnesota, USA) for kindly providing anti-a4(IV) antibody(MAbS5). This work was supported by a grant for "Progressive Renal
Disease" from the Ministry of Health and Welfare research project for
"Specially selected diseases."
Reprint requests to Dr. Norishige Yoshikawa, Department of Pediatrics,
Kobe University School of Medicine, 5-1 Kusunoki-cho 7 chome, Chuo-ku,
Kobe, 650 Japan.
References
1. ALPORT AC: Hereditary familial congenital haemorrhagic nephritis.
BrMedJ 1:504—506, 1927
2. HINGI..Is N, GRUNFELD JP, Bois E: Characteristic ultrastructural
lesion of the glomerular basement membrane in progressive heredi-
tary nephritis (Alport's syndrome). Lab Invest 27:473—487, 1972
3. SPEAR GS, SLUSSER RJ: Alport's syndrome. Emphasizing electron
microscopic studies of the glomerulus. Am J Pathol 69:213—224, 1972
4. CHURG J, SHERMAN RL: Pathologic characteristics of hereditary
nephritis. Arch Pathol 95:374—379, 1973
5. YOSHIKAWA N, CAMERON AH, WI-nm RH: The glomerular basal
lamina in hereditary nephritis. J Pathol 135:199—209, 1981
6. YOSHIKAWA N, WHITE RH, CAMERON AH: Familial hematuria;
clinico-pathological correlations. Clin Nephrol 17:172—182, 1982
7. HABIB R, GUBLER MC, HINGLAIs N, NOEL LH, DROZ D, LEVY M,
MAHIEU P, F0IDART JM, PERRIN D, Bois E, GRUNFELO JP: Alport's
syndrome: Experience at Hôpital Necker. Kidney mt 21 (Suppl
11):S20—S28, 1982
8. YosHnZAwA N, MATSUYAMA S, ITO H, HAJIKANo H, MATSUO T:
Nonfamiial hematuria associated with glomerular basement mem-
brane alterations characteristic of hereditary nephritis: Comparison
with hereditary nephritis. J Pediatr 111:519—524, 1987
9. Yosiiw N, ITo H, MATSUYAMA S, HAZIKANO H, OKADA S,
MATSUO T: Hereditary nephritis in children with and without charac-
teristic glomerular basement membrane alterations. Clin Nephrol
30:122—127, 1988
10. GRUNFELD JP: The clinical spectrum of hereditary nephritis [clinical
conference]. Kidney mt 27:83—92, 1985
11. FEINGOLD J, Bois E, CHOMPRET A, BROYER M, GUBLER MC, GRUN-
FELD JP: Genetic heterogeneity of Alport syndrome. Kidney Int
27:672—677, 1985
12. A'nuN CL, GREGORY MC, BORDER WA: Alport syndrome (chapt 19),
in Diseases of the Kidney (4th ed), edited by SCHRIER RW,
Gorrsc}iAIK CW, Boston, Little, Brown, 1988, pp 617— 641
13. JOHAN5SON C, BuTKowsIu RJ, WIESLANDER J: The structural organi-
zation of type IV collagen. Identification of three NC1 populations in
the glomerular basement membrane. J Biol Chem 267:24533—24537,
1992
14. ZHOU J, Mocrnzuiu T, SMEET5 H, ANTIGNAC C, LAURII..A F, PAEPE
An, TRYGGVASON K, REEDERS ST: Deletion of the paired a5(IV) and
a6(IV) collagen genes in inherited smooth muscle tumors. Science
261:1167—1169, 1993
15. TIMPL R, WIEDEMANN H, v DELDEN V, FURTRMAYR H, Kui-n' K: A
network model for the organization of type IV collagen molecules in
basement membranes. EurJ Biochem 120:203—211, 1981
16. OLSON DL, ANAND SK, LANDING BH, HEUSER E, GRUSHKJN CM,
LIEBERMAN E: Diagnosis of hereditary nephritis by failure of glomer-
uli to bind anti-glomerular basement membrane antibodies. J Pediatr
96:697—699, 1980
17. McCoY RC, JOHNSON HK, STONE WJ, WILSON CB: Absence of
nephritogenic GBM antigen(s) in some patients with hereditary
nephritis. Kidney mt 21:642—652, 1982
18. JENIs EH, VALESKI JE, CALCAGNO FL: Variability of anti-GBM
binding in hereditary nephritis. Gun Nephrol 15:111—114, 1981
19, MILLINER DS, PIERIDES AM, HOLLEY KE: Renal transplantation in
Alport's syndrome: Anti-glomerular basement membrane glomerulo-
nephritis in the allograft. Mayo Gun Proc 57:35—43, 1982
20. JEIW K, KIM Y, VERNIER RL, FIsH AJ, MICHAEL AF: Absence of
Goodpasture's antigen in male patients with familial nephritis. Am J
Kidney Dis 2:626—629, 1983
21. JERAJ K, FISH AJ, Y0SHI0IA K, MICHAEL AF: Development and
heterogeneity of antigens in the immature nephron. Reactivity with
Nakanishi et al: Type IV collagen in heredita,y nephritis 1421
human antiglomerular basement membrane autoantibodies. Am J
Pathol 117:180-483, 1984
22. KASHTAN CE, FIsH AJ, KLEI'PEL MM, YOSHIOKA K, MICHAEL AF:
Nephritogenic antigen determinants in epidermal and renal basement
membranes of kindreds with Alport-type familial nephritis. J Clin
Invest 78:1035—1044, 1986
23. KAsFITAN CE, ATKIN CL, GREGORY MC, MICHAEL AF: Identification
of variant Alport phenotypes using an Alport-specific antibody probe.
Kidney mt 36:669—674, 1989
24. SAUS J, WIESLANDER J, LANGEVELD JP, QUINONES S, HUDSON BG:
Identification of the Goodpasture antigen as the a3(IV) chain of
collagen IV. J Biol Chem 263:13374—13380, 1988
25. TURNER N, MASON PJ, BROWN R, Fox M, POVEY S, REES A, PUSEY
CD: Molecular cloning of the human Goodpasture antigen demon-
strates it to be the a3 chain of type IV collagen. J Gun Invest
89:592—601, 1992
26. KLEPPEL MM, FAN WW, CHEONG HI, KASHTAN CE, MICHAEL AF:
Immunochemical studies of the Alport antigen. Kidney mt 41:1629—
1637, 1992
27. MoRRIsoN KE, MARIYAMA M, YANG FT, REEDERS ST: Sequence and
localization of a partial eDNA encoding the human a3 chain of type
IV collagen. Am J Hum Genet 49:545—554, 1991
28. HOSTIKKA SL, EDDY RL, BYERS MG, HOYHTYA M, SHOWS TB,
TRYGGVASON K: Identification of a distinct type IV collagen a chain
with restricted kidney distribution and assignment of its gene to the
locus of X chromosome-linked Alport syndrome. Proc Nail Acad Sci
USA 87:1606—1610, 1990
29. BARKER DF, HOSTIKKA SL, ZHOU J, CHOW LT, OLIPHANT AR,
GERKEN SC, GREGORY MC, SKOLNICK MH, ATKIN CL, TRYGGVASON
K: Identification of mutations in the COL4A5 collagen gene in Alport
syndrome. Science 248:1224—1227, 1990
30. TRYGGVASON K, ZHOU J, HOSTHxA SL, SHOWS TB: Molecular
genetics of Alport syndrome. Kidney mt 43:38—44, 1993
31. MOCHIZUKI T, MARIYAMA M, SMEETS HIM, LEMMINK HH, PIRs0N Y,
VERELLEN C, ANTIGNAC C, GUBLER MC, REEDERS ST: Identification
of mutations in the a3 and a4 type IV collagen genes in autosomal
resessive Alport syndrome. (abstract) JAm Soc Nephrol 4:819, 1993
32. YOSHIKAWA N, HASHIMOTO H, KATAYAMA Y, YAMADA Y, MATSUO T:
The thin glomerular basement membrane in children with haematu-
na. J Pathol 142:253—257, 1984
33. Btjmowsii RI, WIESLANDER I, KLEPPEL MM, MICHAEL AF, FISH AJ:
Basement membrane collagen in the kidney: Regional localization of
novel chains related to collagen IV. Kidney mt 35:1195—1202, 1989
34. JoHANssor C, BUTKOWSKI RJ, WIESLANDER J: Characterization of
monoclonal antibodies to the globular domain of collagen IV. Connect
Tissue Res 25:229—241, 1991
35. KLEPPEL MM, MICHAEL AF: Expression of novel basement membrane
components in the developing human kidney and eye. Am J Anat
187:165—174, 1990
36. KLEPPEL MM, SANTI PA, CAMERON JD, WIESLANDER J, MICHAEL AF:
Human tissue distribution of novel basement membrane collagen. Am
JPathol 134:813—825, 1989
37. Sro Y, KAGAWA M, RAuF S, NAIT0 I, MORITOH C, OKIGAKI T:
Isologous monoclonal antibodies can induce anti-GBM glomerulone-
phritis in rats. J Pathol 168:221—227, 1992
38. MATSUKURA H, INABA 5, OKADA T, NAITO I, KAGAWA M, Swo Y:
Monoclonal anti-a4 chain of type IV collagen in Alport syndrome.
(abstract) Proceeding of the 36th Annual Meeting of Japanese Society of
Nephrology, 1993 p 367
39. Yos-iioc K, HIN0 5, TAKEMURA T, MAKI 5, WIESLANDER J, Tim-
KOSHI Y, MAKINO H, KAGAWA M, SADO Y, KASHTAN CE: Type IV
collagen a5 chain: Normal distribution and abnormalities in X-linked
Alport syndrome revealed by monoclonal antibody. Am J Pathol
144:986—996, 1994
40. YOSHI0KA K, MICHAEL AF, VELO5A J, FISH AS: Detection of hidden
nephritogenic antigen determinants in human renal and nonrenal
basement membranes. Am J Pathol 121:156—165, 1985
41. SAVAGE CO, PUSEY CD, KERSHAW MJ, CASHMAN SJ, HARRISON P,
HARTLEY B, TURNER DR, CAMERON JS, Ev.s DJ, LOCKWOOD CM:
The Goodpasture antigen in Alport's syndrome: Studies with a
monoclonal antibody. Kidney Int 30:107—112, 1986
42. SAVAGE CO, REED A, KERSHAW M, PlNcorr J, PUSEY CD, DILLON
MJ, BARRATIT TM, L0QW000 CM: Use of a monoclonal antibody in
differential diagnosis of children with haematuria and hereditary
nephnitis. Lancet 1:1459—1461, 1986
43. KASHTAN CE, KLEPPEL MM, BUTKOWSKI RJ, MICHAEL AF, FISH Al:
Alport syndrome, basement membranes and collagen. Pediatr Nephrol
4:523—532, 1990
44. REEDERS ST: Molecular genetics of hereditary nephnitis [clinical
conference]. Kidney Int 42:783—792, 1992
45. GUBLER MC, ANTIGNAC C, KNEBELMANN B: Inherited glomerular
disease (chapt 28), in Pediatric Nephrology (3rd ed), edited by HOLLI-
DAY MA, BAKtArr TM, AVNER ED, Baltimore, Williams & Wilkins,
1994, pp 515—536
46. KASHTAN CE, TOCHIMARU H, SIBLEY RK, MICHAEL AF, VERNIER RL:
Hereditary nephnitis (Alport's syndrome) and benign recurrent hema-
tuna (thin glomerular basement membrane disease) (chapt 38), in
Renal Pathology with Clinical and Functional Correlations, edited by
TISHER CC, BRENNER BM, Philadelphia, SB. Lippincott Company,
1989, pp 1164—1190
